Evidence map›Paper›PMID 29875384›Full record

ArticleNature communications2018

Manipulating type-I and type-II Dirac polaritons in cavity-embedded honeycomb metasurfaces.

Charlie-Ray Mann, Thomas J Sturges, Guillaume Weick, William L Barnes, Eros Mariani

Abstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Charlie-Ray MannEPSRC Centre for Doctoral Training in Metamaterials (XM2), Department of Physics and Astronomy, University of Exeter, Exeter, EX4 4QL, UK. cm433@exeter.ac.uk.ORCID http://orcid.org/0000-0003-1320-2624
Thomas J SturgesEPSRC Centre for Doctoral Training in Metamaterials (XM2), Department of Physics and Astronomy, University of Exeter, Exeter, EX4 4QL, UK.ORCID http://orcid.org/0000-0003-1320-2843
Guillaume WeickUniversité de Strasbourg, CNRS, Institut de Physique et Chimie des Matériaux de Strasbourg, UMR 7504, F-67000, Strasbourg, France.
William L BarnesEPSRC Centre for Doctoral Training in Metamaterials (XM2), Department of Physics and Astronomy, University of Exeter, Exeter, EX4 4QL, UK.ORCID http://orcid.org/0000-0002-9474-5534
Eros MarianiEPSRC Centre for Doctoral Training in Metamaterials (XM2), Department of Physics and Astronomy, University of Exeter, Exeter, EX4 4QL, UK. E.Mariani@exeter.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pseudorelativistic Dirac quasiparticles have emerged in a plethora of artificial graphene systems that mimic the underlying honeycomb symmetry of graphene. However, it is notoriously difficult to manipulate their properties without modifying the lattice structure. Here we theoretically investigate polaritons supported by honeycomb metasurfaces and, despite the trivial nature of the resonant elements, we unveil rich Dirac physics stemming from a non-trivial winding in the light-matter interaction. The metasurfaces simultaneously exhibit two distinct species of massless Dirac polaritons, namely type-I and type-II. By modifying only the photonic environment via an enclosing cavity, one can manipulate the location of the type-II Dirac points, leading to qualitatively different polariton phases. This enables one to alter the fundamental properties of the emergent Dirac polaritons while preserving the lattice structure-a unique scenario which has no analog in real or artificial graphene systems. Exploiting the photonic environment will thus give rise to unexplored Dirac physics at the subwavelength scale.

Identifiers

PMID29875384
PMCPMC5989260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.